Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Developmental, Psychosocial and Learning Problems

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 5 · 71.4%Low 2 · 28.6%Moderate 0 · 0%High 0 · 0%

Mood stabilisers vs placebo

BPD symptom severity Measured by: clinicians and self‐rated Timing of outcome assessment: end of treatment · patients with borderline personality disorder

1 finding from 1 review

Pharmacological interventions for people with borderline personality disorder 2022 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 265 participants
Very low

Mood stabilisers vs placebo

Self‐harm Measured by: clinicians Timing of outcome assessment: end of treatment · patients with borderline personality disorder

It is very uncertain whether mood stabilisers changes self‐harm Timing of outcome assessment: end of treatment (52 weeks… compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for people with borderline personality disorder 2022 · Cochrane Headline outcomes only
RR 1.08 [0.79, 1.48]
1 study · 276 participants
Very low

Mood stabilisers vs placebo

Suicide‐related outcomes Timing of outcome assessment: end of treatment (6 to 12 weeks treatment duration) · patients with borderline personality disorder

1 finding from 1 review

Pharmacological interventions for people with borderline personality disorder 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 44 participants
Very low

Mood stabilisers vs placebo

Psychosocial functioning Measured by: clinicians and self‐rated Timing of outcome assessment: end of treatment · patients with borderline personality disorder

1 finding from 1 review

Pharmacological interventions for people with borderline personality disorder 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 214 participants
Very low

Mood stabilisers vs placebo

Interpersonal problems Timing of outcome assessment: end of treatment (32 days to 24 weeks) · patients with borderline personality disorder

1 finding from 1 review

Pharmacological interventions for people with borderline personality disorder 2022 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 300 participants
Low

Mood stabilisers vs placebo

Attrition Timing of outcome assessment: end of treatment · patients with borderline personality disorder

Mood stabilisers may leads to lower attrition Timing of outcome assessment: end of treatment (32 days to… compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for people with borderline personality disorder 2022 · Cochrane Headline outcomes only
RR 0.89
9 studies · 530 participants
Low

Mood stabilisers vs placebo

Non‐serious adverse events Timing of outcome assessment: end of treatment · patients with borderline personality disorder

It is very uncertain whether mood stabilisers changes non‐serious adverse events Timing of outcome assessment: end of… compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for people with borderline personality disorder 2022 · Cochrane Headline outcomes only
RR 0.84
1 study · 276 participants
Very low